A Microneurography Study of NaV1.8 Inhibition in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

March 22, 2025

Study Completion Date

April 4, 2025

Conditions

Pain

Interventions

DRUG

VX-150

Suspension for oral administration.

DRUG

VX-548

Solution or suspension for oral administration.

DRUG

VX-993

Suspension for oral administration.

DRUG

Placebo

Suspension for oral administration.

Trial Locations (1)

MAC Clinical Research, Manchester

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT06420765 - A Microneurography Study of NaV1.8 Inhibition in Healthy Adults | Biotech Hunter | Biotech Hunter